M.C. Dubroeucq

2.2k total citations
24 papers, 2.0k citations indexed

About

M.C. Dubroeucq is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, M.C. Dubroeucq has authored 24 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 12 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in M.C. Dubroeucq's work include Neuroscience and Neuropharmacology Research (17 papers), Receptor Mechanisms and Signaling (6 papers) and Synthesis and pharmacology of benzodiazepine derivatives (3 papers). M.C. Dubroeucq is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Receptor Mechanisms and Signaling (6 papers) and Synthesis and pharmacology of benzodiazepine derivatives (3 papers). M.C. Dubroeucq collaborates with scholars based in France and United States. M.C. Dubroeucq's co-authors include C. Guérémy, C. Renault, A. Uzan, G. Le Fur, Jesús Bénavidès, F. Imbault, A. Flamier, F. Guilloux, Assunta Impérato and M. Reibaud and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M.C. Dubroeucq

24 papers receiving 1.8k citations

Peers

Countries citing papers authored by M.C. Dubroeucq

Since Specialization

Citations

This map shows the geographic impact of M.C. Dubroeucq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Dubroeucq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Dubroeucq more than expected).

Fields of papers citing papers by M.C. Dubroeucq

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.C. Dubroeucq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Dubroeucq. The network helps show where M.C. Dubroeucq may publish in the future.

Co-authorship network of co-authors of M.C. Dubroeucq

This figure shows the co-authorship network connecting the top 25 collaborators of M.C. Dubroeucq. A scholar is included among the top collaborators of M.C. Dubroeucq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. Dubroeucq. M.C. Dubroeucq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and pharmacological properties of 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, a new competitive AMPA/KA receptor antagonist 1999 ·Drug Development Research ·Serge Mignani, (unknown), Michel Barreau, (unknown), (unknown), Alain Boireau, Dominique Damour, (unknown), M.C. Dubroeucq, (unknown), Assunta Impérato, Patrick Jimonet, Jeremy Pratt, John C.R. Randle, M. Reibaud, Yves Ribeill, Jean‐Marie Stutzmann	9
2	Complex pharmacology of natural cannabivoids: Evidence for partial agonist activity of Δ9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors 1998 ·Life Sciences ·François Petitet, (unknown), M. Reibaud, Assunta Impérato, M.C. Dubroeucq	167
3	P.6.041 In vitro and in vivo characterization of CP-154,526, a non-peptide CRF1 receptor antagonist with partial agonist properties 1997 ·European Neuropsychopharmacology ·(unknown), Marie‐Claude Burgevin, (unknown), (unknown), (unknown), Assunta Impérato, M.C. Dubroeucq	6
4	RP 73870, a gastrin/cholecystokinin-B receptor antagonist with potent anti-ulcer activity in the rat. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·Charles Pendley, Leo R. Fitzpatrick, (unknown), Mary A. Davis, (unknown), (unknown), Philìppe Bertrand, Claude Guyon, M.C. Dubroeucq, G.E. Martin	34
5	The Ureidoacetamides, a Novel Family of Non‐peptide CCK‐B/Gastrin Antagonists 1994 ·Annals of the New York Academy of Sciences ·Georg Andrees Böhme, Philìppe Bertrand, Claude Guyon, Marc Capet, Charles Pendley, J.M. Stutzmann, Adam Doble, M.C. Dubroeucq, Gillian Martin, J.C. Blanchard	10
6	Photoaffinity labeling of peripheral-type benzodiazepine-binding sites. 1987 ·Molecular Pharmacology ·Adam Doble, (unknown), Marie‐Claude Burgevin, Jean Ménager, A. Uzan, M.C. Dubroeucq, C. Renault, C. Guérémy, G. Le Fur	71
7	PK 11195, an antagonist of peripheral type benzodiazepine receptors, modulates BAY K8644 sensitive but not β- or H2-receptor sensitive voltage operated calcium channels in the guinea pig heart 1986 ·Life Sciences ·M Mestre, (unknown), G. Néliat, A. Uzan, C. Renault, M.C. Dubroeucq, C. Guérémy, Adam Doble, G. Le Fur	21
8	Stereoselective inhibition of the binding of [3H]PK 11195 to peripheral-type benzodiazepine binding sites by a quinolinepropanamide derivative 1986 ·European Journal of Pharmacology ·M.C. Dubroeucq, Jesús Bénavidès, Adam Doble, F. Guilloux, (unknown), (unknown), Philìppe Bertrand, C. Guérémy, C. Renault, André Uzan, Gérard Le Fur	31
9	PK 11195, an antagonist of peripheral benzodiazepine receptors, reduces ventricular arrhythmias during myocardial ischemia and reperfusion in the dog 1985 ·European Journal of Pharmacology ·(unknown), (unknown), André Uzan, C. Guérémy, C. Renault, M.C. Dubroeucq, Gérard Le Fur	36
10	Electrophysiological and pharmacological evidence that peripheral type benzodiazepine receptors are coupled to calcium channels in the heart 1985 ·Life Sciences ·M Mestre, (unknown), Cathérine Belin, A. Uzan, C. Renault, M.C. Dubroeucq, C. Guérémy, Adam Doble, G. Le Fur	124
11	Opposite effects of two ligands for peripheral type benzodiazepine binding sites, PK 11195 and RO5-4864, in a conflict situation in the rat 1985 ·Life Sciences ·J Mizoule, (unknown), A. Uzan, C. Renault, M.C. Dubroeucq, C. Guérémy, G. Le Fur	58
12	Opposite effects of an agonist, R05-4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA/2J mice 1984 ·Life Sciences ·Jesús Bénavidès, F. Guilloux, (unknown), A. Uzan, J Mizoule, C. Renault, M.C. Dubroeucq, C. Guérémy, G. Le Fur	92
13	Histidine modification with diethylpyrocarbonate induces a decrease in the binding of an antagonist, PK 11195, but not of an agonist, R05–4864, of the peripheral benzodiazepine receptors 1984 ·Life Sciences ·Jesús Bénavidès, (unknown), (unknown), (unknown), A. Uzan, C. Renault, M.C. Dubroeucq, C. Guérémy, G. Le Fur	35
14	Characterization of peripheral type benzodiazepine binding sites in human and rat platelets by using [3H]PK 11195. Studies in hypertensive patients 1984 ·Biochemical Pharmacology ·Jesús Bénavidès, Dominique Quarteronet, Pierre‐François Plouin, F. Imbault, (unknown), André Uzan, C. Renault, M.C. Dubroeucq, C. Guérémy, Gérard Le Fur	46
15	Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation 1984 ·Life Sciences ·M Mestre, (unknown), Cathérine Belin, A. Uzan, C. Renault, M.C. Dubroeucq, C. Guérémy, G. Le Fur	112
16	Autoradiographic localization of peripheral benzodiazepine binding sites in the cat brain with [3H]PK 11195 1984 ·Brain Research Bulletin ·Jesús Bénavidès, Helen E. Savaki, C. Malgouris, Catherine Laplace, Marie‐Christine Daniel, (unknown), M. Desban, A. Uzan, M.C. Dubroeucq, C. Renault, C. Guérémy, G. Le Fur	39
17	Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-n-(1-methylpropyl)-3-isoquinolinecarboxamide 1983 ·Life Sciences ·G. Le Fur, (unknown), (unknown), F. Imbault, A. Flamier, Jesús Bénavidès, A. Uzan, C. Renault, M.C. Dubroeucq, C. Guérémy	316
18	Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide 1983 ·Life Sciences ·G. Le Fur, F. Guilloux, Pierre Rufat, Jesús Bénavidès, A. Uzan, C. Renault, M.C. Dubroeucq, C. Guérémy	204
19	Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]R05-4864 and [3H]PK 11195, by thermodynamic studies 1983 ·Life Sciences ·G. Le Fur, (unknown), (unknown), A. Flamier, Jesús Bénavidès, C. Renault, M.C. Dubroeucq, C. Guérémy, A. Uzan	240
20	Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [³H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization 1983 ·Journal of Neurochemistry ·Jesús Bénavidès, Dominique Quarteronet, F. Imbault, C. Malgouris, A. Uzan, C. Renault, M.C. Dubroeucq, C. Guérémy, G. Le Fur	255

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact